Dr. Col's Vape Truths" Video Campaign Fights Misinformation

Aug.12.2022
Dr. Col's Vape Truths" Video Campaign Fights Misinformation
Dr. Col's Vape Truths is a video campaign based on evidence aimed at combating misinformation about vaping in Australia.

The "Dr Col's Vape Truths" video campaign, launched earlier, is an evidence-based initiative on vaping aimed at countering the rampant spread of misinformation by state health departments, particularly in Queensland, New South Wales, and Western Australia.


Mendelsohn announced the event on his website and described it as follows: "Dr. Col's Vape Truths event consists of eight short videos that aim to correct common misconceptions about electronic cigarettes. These videos are based on the Queensland Health Department's misleading and alarmist videos and cover key evidence, including:


The toxicity of vapor is far lower than that of cigarette smoke.


Compared to smoking, electronic cigarettes significantly reduce the risk of developing cancer.


Inhaling nicotine does not cause serious damage to the lungs.


Four mislabeled nicotine-free e-cigarettes were sold on the black market as unreliable disposable products, rather than from reputable companies.


There have never been any deaths caused by nicotine use.


When smokers switch to e-cigarettes, their breathing greatly improves.


Electronic cigarettes are not entirely risk-free, but they are much safer than deadly tobacco cigarettes.


Most of the chemicals present in steam are present in very low doses, and most pose little or no harm.


Nancy Loucas, the executive coordinator of CAPHRA (Coalition of Asia-Pacific Tobacco Harm Reduction Advocates) emphasized the timeliness of the campaign. "Fortunately, the inconvenient truth about e-cigarettes has now reached the laptops of Australians, debunking all the scare tactics that health agencies and officials have been selling against e-cigarettes.


Queensland, New South Wales, and Western Australia are investing significant public funds into a misleading anti-vaping campaign. This is leading to active discouragement of adult smokers in Australia from transitioning to less harmful nicotine alternatives. Dr. Col's Vape Truths offers valuable insight into Australia's misguided anti-vaping stance," she said.


Australian authorities adopt a destructive stance towards reducing the harm caused by tobacco (THR).


Activists from around the world have written a letter to the Australian Department of Health calling for an end to the ongoing attacks on the local e-cigarette industry. This action comes in response to a notice sent by the Western Australia Health Department to e-cigarette shop owners throughout the state, ordering them to cease operations within 14 days. The letter was sent on Wednesday, July 20th.


Seventeen global organizations of electronic cigarette users have signed a letter in support of e-cigarette users in Western Australia. Michael Randell, Director of the global e-cigarette advocacy group World Vapers Alliance, stated that such actions could lead to a public health disaster.


Electronic cigarettes have been a lifeline for over 80 million people trying to quit smoking. They have been recognized as the most successful smoking cessation tool to date, being approved in countries such as the United Kingdom, France, and New Zealand. Closing electronic cigarette stores not only drives users to seek their preferred products through the black market, but it also prevents many smokers from quitting traditional cigarettes as they would struggle to find alternatives on the market. By limiting the use of harm reduction tools while leaving traditional cigarettes on the market, the Western Australian government is opening the door to a public health disaster, said Randall.


This article is compiled from third-party information and is only intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of its contents. The translation of this article is intended solely for exchange and research within the industry.


As the level of translation proficiency may be limited, the translated article may not completely match the original text. Please refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government regarding any domestic, Hong Kong, Macao, Taiwan, and international issues and positions.


The compilation of information retains copyright to the original media and author. If there is any infringement, please contact for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
Company | Ploom AURA’s First Overseas Launch in Switzerland Kicks Off Global Rollout
Company | Ploom AURA’s First Overseas Launch in Switzerland Kicks Off Global Rollout
Japan Tobacco International (JTI) has announced that its next-generation heated-tobacco device, Ploom AURA, has debuted in Switzerland, marking the start of its global launch plan. Switzerland plays a key role as JTI’s global headquarters location. Dagmersellen is one of only four facilities worldwide producing EVO filter mouthpieces, underlining Switzerland’s importance in the company’s global operations.
Sep.02 by 2FIRSTS.ai
Thailand's E-Cigarette Ban Supported by WHO, Government Launches "De-Normalization" Campaign to Tackle Youth E-Cigarette Use
Thailand's E-Cigarette Ban Supported by WHO, Government Launches "De-Normalization" Campaign to Tackle Youth E-Cigarette Use
The WHO supports Thailand’s ongoing e-cigarette import and sales ban, citing harm evidence and the Tobacco Control Framework. ThaiHealth has launched a "de-normalization" campaign to reduce youth e-cigarette use. Surveys show 25% of Thai students have tried e-cigarettes, with usage linked to social environments. E-cigarette companies' commercial and political influence challenges tobacco control efforts.
Aug.06 by 2FIRSTS.ai
France bans oral nicotine products; BAT and Philip Morris slam “counterproductive” move, health groups applaud
France bans oral nicotine products; BAT and Philip Morris slam “counterproductive” move, health groups applaud
France has banned producing, importing, distributing, and consuming oral nicotine products (e.g., nicotine pouches, gum) without parliamentary debate or multi-stakeholder consultation. This has sparked strong opposition from firms like British American Tobacco France and Philip Morris France, which argue it contradicts EU discussions, deprives smokers of reduced-harm alternatives, and lacks scientific basis. However, anti-smoking group Alliance Contre le Tabac hails it as a "victory" for public
Sep.08
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (Hong Kong) recorded revenue of HKD 10.32 billion in the first half of 2025, up 18.5% year-on-year, with gross profit down 1.8%. Net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year. Revenue from the new tobacco export business was HKD 14.6 million, down 66.5% year-on-year.
Aug.22 by 2FIRSTS.ai
Brazilian State of Parana Holds Public Hearing to Address E-Cigarette Risks to Children and Adolescents
Brazilian State of Parana Holds Public Hearing to Address E-Cigarette Risks to Children and Adolescents
Next week, the state legislature in Paraná, Brazil, will hold a public hearing to discuss the potential risks of e-cigarettes.
Sep.05 by 2FIRSTS.ai